Introduction
Early stage breast cancer metastasizes to regional lymph nodes. The most frequent sites of spreading in advanced stages are bones (70%), lungs (66%) and liver (61%) [1] .
Even though skeletal muscles are well vascularized, metastases from breast cancer represent an extremely rare condition. There are a few conditions that may affect the establishment of the tumor emboli in the muscles such as a variable blood flow due to contraction and relaxation of the striated fibers, mechanical destruction, the ability of skeletal muscle to remove lactic acid (which is involved in neovascularization) [2] . We present the case of a young patient with breast cancer and metastasis in the pectoralis muscle.
Case report
A 27-year-old female presented with a palpable lump at 2.30 o'clock in the left breast. Past medical and family history was irrelevant. Ultrasound revealed a suspect hypoechoic, spiculated mass in the upper outer quadrant, so a 3D mammography was performed (fig 1 a, b) . The lesion was highly suspicious for malignancy on both examinations, therefore it was classified according to the Breast Imaging-Reporting and Data System (BI-RADS) as BI-RADS 5 and a percutaneous biopsy was taken. The pathological diagnosis was triple negative invasive ductal carcinoma (IDC NST Gr 3, ER 0%, PR 0%, HER2 -, Ki67 90%).
Subsequently, the patient underwent neoadjuvant chemotherapy (4x Farmorubicin + Cyclophosphamide and 5x Docetaxel), conservative surgery (sectorectomy and lymphadenectomy) and radiation therapy.
Two months after the end of radiation she presented with a 2 mm skin lesion and she was referred for a screening automated breast ultrasound (ABUS). Two hypoechoic masses were detected: one at 2 o'clock, 53.1 mm from the nipple, cranial to the postsurgical scar (partially circumscribed) and the second in the intercos-
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Keywords: automated breast ultrasound, breast cancer, pectoralis metastases DOI: 10.11152/mu-1769 tal space, parasternal, at 10 o'clock, 75.5 mm from the nipple (ill-defined) (Fig 1 c-f ). The examinations were completed with a handheld ultrasound (HHUS), which confirmed the presence of the lesions detected at ABUS and revealed a second lesion in the intercostal space (Fig 1 g, h) . The appearance of the lesions raised the suspicion of local recurrence and pectoralis metastases. The contrast-enhanced breast magnetic resonance imaging (MRI) found that all lesions had a malignant morphology and behavior (Fig 2 a-d) . The diagnosis was confirmed by the ultrasound-guided biopsy of the pectoralis lesions.
The patient started chemotherapy. After a week she underwent a contrast-enhanced computed tomography (CT), which revealed mediastinal, supraclavicular and left axillary lymph node metastases, left pleural metastasis and left pleural effusion (Fig 2 e-h) .
Two months later the patient's general condition had worsened and she was hospitalized for acute respiratory failure with bilateral massive pleural effusions, pericardial effusion and multiple bones and subcutaneous metastases with unfavorable evolution to death.
Discussions
Breast cancer represents the most frequent type of cancer in women and the second cause of death due to cancer (after lung cancer), with a mortality rate of 2.6% [3] . Five molecular subtypes of breast cancer are recognized and triple negative subtype (ER-PR-HER2-) is one of them. It constitutes an aggressive form with a high At contrast-enhanced CT, venous phase, axial sections homogeneous enhancement of a subcutaneous mass (e -white dotted arrow), inhomogeneous enhancement of the pectoralis muscle lesions and a small cutaneous lesion representing a permeation nodule (f -yellow circle), mediastinal lymph node metastases (g -black star), homogeneous enhancement of a left pleural lesion (white arrow) associated with left pleural effusion (h) were described. risk of recurrence and an increased risk of death within 2 years of diagnosis [4] .
Ki-67 is a biomarker of tumor proliferation and a prognostic factor in primary breast cancer. Tashima et al established the value of 20% as being the optimal cutoff point for Ki-67 index in their study for neoadjuvant chemotherapy; the mean value in the triple negative tumor was 51.9% [5] . Unfortunately, our patient had a triple negative lesion, with a Ki-67 of 90%, which lead to fulminant worsening of general condition and death.
In advanced disease stages, the risk of developing bone metastases is higher in cases with multiple lymph node metastases, HER2 positive or triple negative breast cancer subtypes [6] . On the other hand, skeletal muscle metastases (SMM) are uncommon. Most of the knowledge regarding this pathology has been achieved through multiple published case reports. In the vast majority of situations, SMM remain asymptomatic (as in our case) and only in a few cases may present as local swelling, pain or muscle impairment [2] . The imaging findings may vary from round/oval lesion with homogeneous enhancement or abscess-like lesion to diffuse infiltrating aspect with inhomogeneous enhancement, multiple intramuscular calcifications or even intramuscular bleeding [7] and differential diagnosis is required [8, 9] .
To the best of our knowledge, in the literature there are about 39 cases of SMM from breast cancer, but none of them in the pectoralis muscle. Some of these cases have been reviewed from the literature or have come from retrospective studies [2, 7, [10] [11] [12] while ten of them have been published as individual case reports [8, 11, [13] [14] [15] [16] [17] [18] [19] .
The detection rate of ABUS is 97% in for lesions larger than 11 mm. The diagnostic performance is similar to that of HHUS except for cases of a multifocal disease in which ABUS seemed to outperform HHUS [20, 21] . In our patient, ABUS not only detected the local recurrence but also drew attention to the ill-defined, hypoechoic lesions located deep in the left intercostal space.
Conclusions
In conclusion: breast cancer in young patients is usually aggressive and can have a bad prognosis. ABUS represents a new screening technique that can be successfully used for detections and follow-up in young patients or patients with dense breast tissue.
